Cystic Fibrosis – Global Clinical Trial Landscape (2024)

Globally, 162,430 individuals are estimated to be living with Cystic Fibrosis (CF). While current treatments manage symptoms and extend lives, limitations and side effects linger. Emerging therapies like gene editing and personalised medicine offer a brighter future. Challenges remain such as access and side effects, but advancements in technology and the emergence of new therapies present ample opportunities In this free paper, discover the latest insight and data on global CF clinical trials in 2024, including the funding and drug development landscapes, prospects, and the opportunities they present for trial providers.